Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Cardiology

  • News

    Novel antiplatelet drug: Hope for efficacy without bleeding?

    April 12, 2021

    A new antiplatelet drug with a completely novel mechanism of action could hold the promise of delivering the holy grail – reducing cardiac events without increasing bleeding.

  • 1
    News

    Longitudinal associations between income changes and incident CVD

    April 2, 2021

    Is there an association between income change and cardiovascular disease (CVD)?

  • News

    AstraZeneca COVID vaccine: Clotting disorder mechanism revealed?

    April 2, 2021

    The vaccine may be linked to a condition that clinically resembles heparin-induced thrombocytopenia and seems to occur mainly in younger women.

  • News

    The role of aspirin in primary prevention of cardiovascular disease

    April 1, 2021

    Does aspirin have a role in primary prevention of cardiovascular disease?

  • 1
    News

    PCI and CABG for left main disease have equal outcomes at 5 years

    March 31, 2021

    In a patient with left main coronary disease, is percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) a better option when considering long-term (5-year) outcomes?

  • 1
    News

    In-hospital mobility impairment in older MI patients predicts postdischarge functional decline

    March 29, 2021

    Does in-hospital mobility of older patients hospitalized for acute myocardial infarction predict overall functional decline after discharge?

  • 1
    News

    Dapagliflozin may cut risk of HF hospitalization in patients with type 2 diabetes

    March 25, 2021

    What is the Food and Drug Administration–approved indication for dapagliflozin (Farxiga)?

  • News

    Low concordance between troponin assays for ACS

    March 25, 2021

    Concordance between high-sensitivity troponin assays was only 37% for a single blood draw, rising to 75% with serial testing, but still changing management decisions in some patients.

  • 1
    News

    ApoB may better predict mortality risk in statin-treated patients

    March 24, 2021

    In the study, measures of apoB and non-HDL cholesterol, but not LDL cholesterol, were associated with increased residual mortality and myocardial infarction risk.

  • 1
    News

    Depression screening after ACS does not change outcomes

    March 23, 2021

    Does systematic screening for depression in acute coronary syndrome (ACS) survivors affect quality of life and depression?

Previous1 … 16 17 18 19 20 … 80Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences